AHS Alta Natural Herbs and Supplements Ltd

Afexa Life Sciences Inc. ("Afexa") (TSX:FXA) wishes to set the record straight.
After a thorough review of our contractual arrangements and other dealings with
Alberta Health Services ("AHS") in relation to our multi-centre pediatric
clinical trial involving COLD-FX(R), we feel clarifying the public record is
required, given the recent media interest in this trial.


In June of 2008 Afexa entered into a contract with Capital Health ("CH") with
respect to our pediatric clinical trial and in May of 2009 the rights and
obligations of CH under such agreement were assumed by AHS. Under the agreement,
AHS undertook to be the Edmonton site for the clinical trial, which involves
sites in three provinces. Dr. Gerry Predy agreed to be the Principal
Investigator for the trial in Edmonton. The clinical trial agreement provides
the standard separation of the trial's funding (the responsibility of Afexa)
from the execution and conducting of the trial (the responsibility of AHS and
the Principal Investigator). Contrary to media reports, Alberta Health Services
is the institution conducting the Edmonton portion of the pediatric clinical
trial on COLD-FX.


The newspaper advertisement which has become the subject of recent media reports
was developed collaboratively by the parties to the clinical trial agreement and
was intended solely to recruit participants for the trial. Advertising by the
institution conducting the clinical trial is a common recruitment method. In
fact, the identical advertisement had previously been used by AHS for just such
purpose for this trial. It should also be noted that the advertisement in
question was approved by the joint AHS/University of Alberta medical-research
ethics board overseeing the trial. Further, the clinical trial itself has
received all required approvals from the medical-research ethics board and
suggestions that the recruitment for the trial has been halted for ethical or
other similar reasons are incorrect. 


Like much of the biotechnology/pharmaceutical industry Afexa works closely with
health authorities, universities and research centres in Canada and the United
States to develop medicines for public health. We are proud of our research
record.

Alta Natural Herbs and S... (TSXV:AHS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Alta Natural Herbs and S... (TSXV:AHS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024